Maziarz, Richard Thomas
- Oregon Health & Science University · Internal Medicine (NIH department code)
From the FY2022 NIH awards this investigator leads as contact PI. The department is the award's.
FY2022 NIH rank #39,285
- Early Career
Researcher identity and coverage
- Current affiliation
- Not verified in ScienceDex.NIH award organizations may differ from a researcher's employer.
- NIH RePORTER identity
- Profile ID unavailableSearch this ID in NIH RePORTER
- ORCID iD
- No ORCID iD on recordA researcher can add one by claiming this profile.
- ScienceDex PI coverage
- FY2017 through FY2022Career claims are limited to the years shown.Metrics use this researcher's latest loaded PI award year; ScienceDex is current through FY2026.
FY2022 award categories
- Internal Medicine
NIH Funding · FY2022
Linked Award Amount
$186.6K
Full award amounts, FY2022
Award Records
1
Records listing this PI
Award-Linked Rank
#39,285
By linked amount among FY2022 PIs
Earliest Year Loaded
2017
ScienceDex PI coverage
Award-linked funding history
Linked NIH award amounts and rank by fiscal year.
FY2022 award records by amount
NIH award records listing Maziarz, Richard Thomas as a PI. Multi-PI records show the full award amount for context.
- 5UG1HL138658-06UG1Contact PINovel Strategies for Assessing and Optimizing Therapy for Minimal Residual Disease after Allogeneic Transplantation for AML and MDSOregon Health & Science University · Internal Medicine (NIH department code)$186.6Kaward amount
Award organization
Organizations that administered FY2022 awards listing Maziarz, Richard Thomas as a PI.
FY2022 award administered by Oregon Health & Science University (OR).
Coverage and award-record milestones
Computed from the fiscal years currently available in ScienceDex.
- 2017First NIH AwardOregon Health & Science University
- 2019$500K Cumulative Funding
- 2022$1M Cumulative Funding